Editorial: Challenges associated with identifying preclinical animal models for the development of immune-based therapies

被引：0
作者：
Jamil, Kainat [1 ]
Sherchand, Shardulendra P. [2 ]
Adhikari, Rajan P. [2 ]
Coosemans, An [1 ]
机构：
[1] Katholieke Univ KU Leuven, Dept Oncol, Lab Tumor Immunol & Immunotherapy, Leuven, Belgium
[2] AbVacc Inc, Bacteriol Immunotherapy, Rockville, MD USA
来源：
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词：
animal; preclinical (in vivo) studies; immunotherapy; immune-based therapeutics; editorial;
D O I：
10.3389/fimmu.2024.1404085
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：3
相关论文
共 48 条
  • [41] Stocking the toolbox-Using preclinical models to understand the development and treatment of immune checkpoint inhibitor-induced immune-related adverse events
    Cina, Morgan L.
    Venegas, Jessica
    Young, Arabella
    IMMUNOLOGICAL REVIEWS, 2023, 318 (01) : 110 - 137
  • [42] Dermatological adverse events associated with immune checkpoint inhibitor-based combinations of anticancer therapies: a systematic review
    Salloum, Antoine
    Habre, Maya
    Chebl, Joanna Abi
    Chebl, Karen Abi
    Atallah, Carl
    Medawar, Georgio
    Kourie, Hampig R.
    IMMUNOTHERAPY, 2022, 14 (06) : 489 - 503
  • [43] Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer
    Talpin, Alice
    Maia, Ana
    Carpier, Jean-Marie
    Kulakowski, Guillaume
    Aubergeon, Lucie
    Kervevan, Jerome
    Gaal, Camille
    Strozzi, Francesco
    Billerey, Coline
    Amable, Ludivine
    Mersceman, Tifanny
    Garnier, Alexandrine
    Oliveira, Catia
    Calderon, Carolina
    Bachrouche, Diana
    Ventujol, Chloe
    Bernard, Lea
    Manteau, Amandine
    Martinez, Jennifer
    Bonnet, Michael
    Noguerol, Julie
    Laviolette, Karl
    Boullerot, Laura
    Malfroy, Marine
    Chevalier, Gregoire
    Adotevi, Olivier
    Joffre, Olivier
    Idbaih, Ahmed
    Vieito, Maria
    Ghiringhelli, Francois
    Stradella, Agostina
    Tabatabai, Ghazaleh
    Burger, Michael C.
    Mildenberger, Iris
    Herrlinger, Ulrich
    Reardon, David A.
    Wick, Wolfgang
    Gouttefangeas, Cecile
    Bonny, Christophe
    Chene, Laurent
    Gamelas Magalhaes, Joao
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 15 (02)
  • [44] Editorial: The mechanism of immune cells in the development of inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC)
    Russo, Edda
    Yin, Kai
    Sheng, Xiumei
    Mao, Fei
    Amedei, Amedeo
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [45] Challenges in the harmonization of immune monitoring studies and trial design for cell-based therapies in the context of hematopoietic cell transplantation for pediatric cancer patients
    Nierkens, Stefan
    Lankester, Arjan C.
    Egeler, R. Maarten
    Bader, Peter
    Locatelli, Franco
    Pulsipher, Michael A.
    Bollard, Cathepine M.
    Boelens, Jaap-Jan
    CYTOTHERAPY, 2015, 17 (12) : 1667 - 1674
  • [46] Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell
    Sun, Yimeng
    Yao, Lin
    Man, Changfeng
    Gao, Zhenjun
    He, Rong
    Fan, Yu
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [47] Hepatitis associated with immune checkpoint inhibitors-based combinations of other therapies: A real-world pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database
    Li, Zhaohui
    Zhou, Zixiang
    Zhang, Nan
    Tian, Binhe
    Chen, Xiangqi
    Zhao, Haitao
    Wang, Hanping
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 74 (01)
  • [48] A Novel Hydrogel-Based 3D In Vitro Tumor Panel of 30 PDX Models Incorporates Tumor, Stromal and Immune Cell Compartments of the TME for the Screening of Oncology and Immuno-Therapies
    Xue, Bin
    Schueler, Julia
    Harrod, Christopher M.
    Lashuk, Kanstantsin
    Bomya, Zoji
    Hribar, Kolin C.
    CELLS, 2023, 12 (08)
12345